Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for Charcot-Marie-Tooth disease type 2T has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
4 publications have been identified in PubMed for Charcot-Marie-Tooth disease type 2T. Research spans Epidemiology / Natural History (50%), Diagnostic / Biomarker (25%), and Case Report / Case Series (25%).
Lerint AN (2026). [PMID: 41799927](https://pubmed.ncbi.nlm.nih.gov/41799927/). *Journal of central nervous system disease*. [Case Report / Case Series]
Salami Z (2026). [PMID: 41538925](https://pubmed.ncbi.nlm.nih.gov/41538925/). *Neuromuscular disorders : NMD*. [Epidemiology / Natural History]
Yalcouyé A (2025). [PMID: 40320863](https://pubmed.ncbi.nlm.nih.gov/40320863/). *Brain and behavior*. [Epidemiology / Natural History]
Fajardo JE (2025). [PMID: 41332845](https://pubmed.ncbi.nlm.nih.gov/41332845/). *medRxiv : the preprint server for health sciences*. [Diagnostic / Biomarker]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:56 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Charcot-Marie-Tooth disease type 2T